Israeli Company Joins U.S. Trial on Ulcerative Colitis Treatment
Israeli company Evinature's CurQD, a curcumin and QingDai blend, will be part of a US trial at Mount Sinai and University of Chicago for ulcerative colitis.
Israeli company Evinature's CurQD, a curcumin and QingDai blend, will be part of a US trial at Mount Sinai and University of Chicago for ulcerative colitis.
Israeli firm Evinature's CurQD will be part of a U.S. DoD trial for ulcerative colitis, involving Mount Sinai and University of Chicago.